Skip to main content
Erschienen in: Rheumatology International 8/2016

20.06.2016 | Imaging

Circulating microparticles bearing Fibrin associated with whole-body 18FDG-PET: diagnostic tools to detect paraneoplastic polymyalgia rheumatica

verfasst von: Diane Mege, Serge Cammilleri, Olivier Mundler, Françoise Dignat-George, Christophe Dubois, Laurence Panicot-Dubois, Sandrine Guis

Erschienen in: Rheumatology International | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Polymyalgia rheumatica (PMR), a chronic inflammatory rheumatism, can be the expression of a paraneoplastic syndrome. The same clinical symptoms are frequently observed at the early stage of the benign and malignant forms. Here, our aim was to develop diagnostic tools to differentiate paraneoplastic PMR from essential PMR. We combined an 18FDG-PET and detection of circulating procoagulant microparticles (MPs), such as fibrin positive (FibMPs), by flow cytometry. Two patients with PMR and a similar profile were selected. In the two patients, the 18FDG-PET revealed a hypermetabolic focus. However, the concentrations of fibrin+/annexin+ microparticles detected were (10 times higher in one of the two patients, who was later found to have breast cancer. The association of 18FDG-PET and the detection of microparticle fibrin positives by flow cytometry allows separating essential PMR (hypermetabolism by 18FDG-PET, low FibMPs) from paraneoplastic PMR.
Literatur
1.
Zurück zum Zitat Fam AG (2000) Paraneoplastic rheumatic syndromes. Baillieres Best Pract Res Clin Rheumatol 14(3):515–533CrossRefPubMed Fam AG (2000) Paraneoplastic rheumatic syndromes. Baillieres Best Pract Res Clin Rheumatol 14(3):515–533CrossRefPubMed
2.
Zurück zum Zitat Alias A, Rodriguez EJ, Bateman HE, Sterrett AG, Valeriano-Marcet J (2012) Rheumatology and oncology: an updated review of rheumatic manifestations of malignancy and anti-neoplastic therapy. Bull NYU Hosp Jt Dis 70(2):109–114PubMed Alias A, Rodriguez EJ, Bateman HE, Sterrett AG, Valeriano-Marcet J (2012) Rheumatology and oncology: an updated review of rheumatic manifestations of malignancy and anti-neoplastic therapy. Bull NYU Hosp Jt Dis 70(2):109–114PubMed
3.
Zurück zum Zitat Hakkou J, Rostom S, Bahiri R, Hajjaj-Hassouni N (2012) Paraneoplastic rheumatic syndromes: report of eight cases and review of literature. Rheumatol Int 32(6):1485–1489CrossRefPubMed Hakkou J, Rostom S, Bahiri R, Hajjaj-Hassouni N (2012) Paraneoplastic rheumatic syndromes: report of eight cases and review of literature. Rheumatol Int 32(6):1485–1489CrossRefPubMed
4.
Zurück zum Zitat Morel J, Deschamps V, Toussirot E, Pertuiset E, Sordet C, Kieffer P, Berthelot JM, Champagne H, Mariette X, Combe B (2008) Characteristics and survival of 26 patients with paraneoplastic arthritis. Ann Rheum Dis 67(2):244–247CrossRefPubMed Morel J, Deschamps V, Toussirot E, Pertuiset E, Sordet C, Kieffer P, Berthelot JM, Champagne H, Mariette X, Combe B (2008) Characteristics and survival of 26 patients with paraneoplastic arthritis. Ann Rheum Dis 67(2):244–247CrossRefPubMed
5.
Zurück zum Zitat Linke R, Voltz R (2008) FDG-pet in paraneoplastic syndromes. Recent Results Cancer Res 170:203–211CrossRefPubMed Linke R, Voltz R (2008) FDG-pet in paraneoplastic syndromes. Recent Results Cancer Res 170:203–211CrossRefPubMed
6.
Zurück zum Zitat Cammilleri S, Guzian MC, Mattei JP, Mundler O, Guis S (2013) Whole-body (18) FDG-PET in an arthritis paraneoplastic syndrome revealed an underlying hematological neoplasm. Case Rep Med 594704 Cammilleri S, Guzian MC, Mattei JP, Mundler O, Guis S (2013) Whole-body (18) FDG-PET in an arthritis paraneoplastic syndrome revealed an underlying hematological neoplasm. Case Rep Med 594704
7.
Zurück zum Zitat Danve A, O’Dell J (2015) The role of 18Fluorodeoxyglucose positron emission tomography scanning in the diagnosis and management of systemic vasculitis. Int J Rheul Dis 18(7):714–724CrossRef Danve A, O’Dell J (2015) The role of 18Fluorodeoxyglucose positron emission tomography scanning in the diagnosis and management of systemic vasculitis. Int J Rheul Dis 18(7):714–724CrossRef
8.
Zurück zum Zitat Lehman VT, Barrick BJ, Pittelkow MR, Peller PJ, Camilleri MJ, Lehman JS (2015) Diagnostic imaging in paraneoplastic autoimmune multiorgan syndrome: retrospective single site study and literature review of 225 patients. Int J Dermatol 54(4):424–437CrossRefPubMed Lehman VT, Barrick BJ, Pittelkow MR, Peller PJ, Camilleri MJ, Lehman JS (2015) Diagnostic imaging in paraneoplastic autoimmune multiorgan syndrome: retrospective single site study and literature review of 225 patients. Int J Dermatol 54(4):424–437CrossRefPubMed
9.
Zurück zum Zitat Robert S, Lacroix R, Poncelet P, Harhouri K, Bouriche T, Judicone C, Wischhusen J, Arnaud L, Dignat-George F (2012) High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles–brief report. Arterioscler Thromb Vasc Biol 32(4):1054–1058CrossRefPubMed Robert S, Lacroix R, Poncelet P, Harhouri K, Bouriche T, Judicone C, Wischhusen J, Arnaud L, Dignat-George F (2012) High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles–brief report. Arterioscler Thromb Vasc Biol 32(4):1054–1058CrossRefPubMed
10.
Zurück zum Zitat Piccin A, Murphy WG, Smith OP (2007) Circulating microparticles: pathophysiology and clinical implications. Blood Rev 21(3):157–171CrossRefPubMed Piccin A, Murphy WG, Smith OP (2007) Circulating microparticles: pathophysiology and clinical implications. Blood Rev 21(3):157–171CrossRefPubMed
11.
Zurück zum Zitat Mezouar S, Darbousset R, Dignat-George F, Panicot-Dubois L, Dubois C (2015) Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo. Int J Cancer 136(2):462–475CrossRefPubMed Mezouar S, Darbousset R, Dignat-George F, Panicot-Dubois L, Dubois C (2015) Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo. Int J Cancer 136(2):462–475CrossRefPubMed
12.
Zurück zum Zitat Mezouar S, Mege D, Darbousset R, Farge D, Debourdeau P, Dignat-George F, Panicot-Dubois L, Dubois C (2014) Involvement of platelet-derived microparticles in tumor progression and thrombosis. Semin Oncol 41(3):346–358CrossRefPubMed Mezouar S, Mege D, Darbousset R, Farge D, Debourdeau P, Dignat-George F, Panicot-Dubois L, Dubois C (2014) Involvement of platelet-derived microparticles in tumor progression and thrombosis. Semin Oncol 41(3):346–358CrossRefPubMed
14.
Zurück zum Zitat Geddings JE, Mackman N (2013) Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood 122(11):1873–1880CrossRefPubMedPubMedCentral Geddings JE, Mackman N (2013) Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood 122(11):1873–1880CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J, Dignat-George F (2012) Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost 10(3):437–446CrossRefPubMed Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J, Dignat-George F (2012) Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost 10(3):437–446CrossRefPubMed
16.
Zurück zum Zitat Thomas GM, Panicot-Dubois L, Lacroix R, Dignat-George F, Lombardo D, Dubois C (2009) Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. J Exp Med 206(9):1913–1927CrossRefPubMedPubMedCentral Thomas GM, Panicot-Dubois L, Lacroix R, Dignat-George F, Lombardo D, Dubois C (2009) Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. J Exp Med 206(9):1913–1927CrossRefPubMedPubMedCentral
Metadaten
Titel
Circulating microparticles bearing Fibrin associated with whole-body 18FDG-PET: diagnostic tools to detect paraneoplastic polymyalgia rheumatica
verfasst von
Diane Mege
Serge Cammilleri
Olivier Mundler
Françoise Dignat-George
Christophe Dubois
Laurence Panicot-Dubois
Sandrine Guis
Publikationsdatum
20.06.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 8/2016
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-016-3510-7

Weitere Artikel der Ausgabe 8/2016

Rheumatology International 8/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.